Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2010

Open Access 01-12-2010 | Case report

Major surgery in an osteosarcoma patient refusing blood transfusion: case report

Authors: Amreeta Dhanoa, Vivek A Singh, Rukmanikanthan Shanmugam, Raja Rajendram

Published in: World Journal of Surgical Oncology | Issue 1/2010

Login to get access

Abstract

We describe an unusual case of osteosarcoma in a Jehovah's Witness patient who underwent chemotherapy and major surgery without the need for blood transfusion. This 16-year-old girl presented with osteosarcoma of the right proximal tibia requiring proximal tibia resection, followed by endoprosthesis replacement. She was successfully treated with neoadjuvant chemotherapy and surgery with the support of haematinics, granulocyte colony-stimulating factor, recombinant erythropoietin and intraoperative normovolaemic haemodilution. This case illustrates the importance of maintaining effective, open communication and exploring acceptable therapeutic alternative in the management of these patients, whilst still respecting their beliefs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Marsh JC, Bevan DH: Hematological care of the Jehovah's Witness patient. Br J Haematol. 2002, 119: 25-37. 10.1046/j.1365-2141.2002.03639.x.CrossRefPubMed Marsh JC, Bevan DH: Hematological care of the Jehovah's Witness patient. Br J Haematol. 2002, 119: 25-37. 10.1046/j.1365-2141.2002.03639.x.CrossRefPubMed
3.
go back to reference Letsoalo JL: Law, blood transfusions and Jehovah's Witnesses. Med Law. 1998, 17: 633-638.PubMed Letsoalo JL: Law, blood transfusions and Jehovah's Witnesses. Med Law. 1998, 17: 633-638.PubMed
4.
go back to reference Hughes DB, Ullery BW, Barie PS: The contemporary approach to the care of Jehovah's Witnesses. J Trauma. 2008, 65: 237-247. 10.1097/TA.0b013e318176cc66.CrossRefPubMed Hughes DB, Ullery BW, Barie PS: The contemporary approach to the care of Jehovah's Witnesses. J Trauma. 2008, 65: 237-247. 10.1097/TA.0b013e318176cc66.CrossRefPubMed
5.
go back to reference Benson K: Management of the Jehovah's Witness oncology patient: perspective of the transfusion service. Cancer Control. 1995, 2: 552-556.PubMed Benson K: Management of the Jehovah's Witness oncology patient: perspective of the transfusion service. Cancer Control. 1995, 2: 552-556.PubMed
6.
go back to reference Trouwborst A, Hangenouw RR, Jeekel J, Ong GL: Hypervolaemic haemodilution in an anaemic Jehovah's Witness. Br J Anaesth. 1990, 64: 646-648. 10.1093/bja/64.5.646.CrossRefPubMed Trouwborst A, Hangenouw RR, Jeekel J, Ong GL: Hypervolaemic haemodilution in an anaemic Jehovah's Witness. Br J Anaesth. 1990, 64: 646-648. 10.1093/bja/64.5.646.CrossRefPubMed
7.
go back to reference Ta HT, Dass CR, Choong PF, Dunstan DE: Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009, 28: 247-263. 10.1007/s10555-009-9186-7.CrossRefPubMed Ta HT, Dass CR, Choong PF, Dunstan DE: Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009, 28: 247-263. 10.1007/s10555-009-9186-7.CrossRefPubMed
8.
go back to reference Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med. 1999, 27: 2346-2350. 10.1097/00003246-199911000-00004.CrossRefPubMed Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med. 1999, 27: 2346-2350. 10.1097/00003246-199911000-00004.CrossRefPubMed
9.
go back to reference Carson JL, Noveck H, Berlin JA, Gould SA: Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002, 42: 812-818. 10.1046/j.1537-2995.2002.00123.x.CrossRefPubMed Carson JL, Noveck H, Berlin JA, Gould SA: Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002, 42: 812-818. 10.1046/j.1537-2995.2002.00123.x.CrossRefPubMed
10.
go back to reference Kitchens CS: Are transfusions overrated? Surgical outcome of Jehovah's Witnesses. Am J Med. 1993, 94: 117-119. 10.1016/0002-9343(93)90171-K.CrossRefPubMed Kitchens CS: Are transfusions overrated? Surgical outcome of Jehovah's Witnesses. Am J Med. 1993, 94: 117-119. 10.1016/0002-9343(93)90171-K.CrossRefPubMed
11.
go back to reference Du X, Williams DA: Interleukin-11: review of molecular, cell biology, and clinical use. Blood. 1997, 89: 3897-3908.PubMed Du X, Williams DA: Interleukin-11: review of molecular, cell biology, and clinical use. Blood. 1997, 89: 3897-3908.PubMed
12.
go back to reference Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy MF: Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev. 2004, CD004269-Review, 4 Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S, Murphy MF: Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev. 2004, CD004269-Review, 4
13.
go back to reference Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U: Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: A two-institutional experience report. Onkologie. 2004, 27: 131-137. 10.1159/000076901.CrossRefPubMed Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U: Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: A two-institutional experience report. Onkologie. 2004, 27: 131-137. 10.1159/000076901.CrossRefPubMed
14.
go back to reference Kronberger M, Fischmeister G, Poetschger U, Gadner H, Zoubek A: Reduction in transfusion requirements with early epoietin alfa treatment in pediatric patients with solid tumors: A case-control study. Pediatr Hematol Oncol. 2002, 19: 95-105. 10.1080/08880010252825687.CrossRefPubMed Kronberger M, Fischmeister G, Poetschger U, Gadner H, Zoubek A: Reduction in transfusion requirements with early epoietin alfa treatment in pediatric patients with solid tumors: A case-control study. Pediatr Hematol Oncol. 2002, 19: 95-105. 10.1080/08880010252825687.CrossRefPubMed
15.
Metadata
Title
Major surgery in an osteosarcoma patient refusing blood transfusion: case report
Authors
Amreeta Dhanoa
Vivek A Singh
Rukmanikanthan Shanmugam
Raja Rajendram
Publication date
01-12-2010
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2010
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-8-96

Other articles of this Issue 1/2010

World Journal of Surgical Oncology 1/2010 Go to the issue